What explains the increasingly volatile mood swings of America’s most important industry?

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026 2026 is set to test AI financing loops as credit tightens and lenders push for revenue proof from high-burn developers.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...